Literature DB >> 23104974

Conducting the ACTIVE randomized trial in hospice care: keys to success.

Robin L Kruse1, Debra Parker Oliver, Elaine Wittenberg-Lyles, George Demiris.   

Abstract

BACKGROUND: Untreated pain is common for patients at the end of life. Informal caregivers, often family or friends of patients, are responsible for working with hospice staff to provide pain management. Interdisciplinary team meetings conducted in hospices every 2 weeks provide an opportunity for hospice staff to communicate about pain management with informal caregivers of hospice patients.
PURPOSE: We present challenges, solutions, and keys strategies for carrying out a randomized trial in the hospice setting.
METHODS: We are conducting the Assessing Caregivers for Team Intervention through Video Encounters (ACTIVE) study to determine whether regular videoconferencing between hospice patients' informal caregivers and the hospice care team alters caregivers' perceptions of pain management and patients' pain. Participants must be primary caregivers for a hospice patient, at least 18 years of age, capable of providing informed consent, and have access to a computer with a high-speed Internet connection or a telephone. We randomized caregivers to participate in biweekly team meetings through video or phone conferencing (intervention) or to receive usual care from the hospice. All patients receive standard hospice care regardless of the group assignment of their informal caregiver.
RESULTS: As of 1 July 2012, there have been 1038 new admissions to the participating hospices. Of 391 cases in which no contact was made, 233 patients had died or had life expectancy less than 14 days. Home visits were made to 271 interested and eligible caregivers; 249 caregivers of 233 patients were randomly assigned to the usual care or intervention arm. Enrollment is on pace to meet recruitment goals. Lessons Learned Thorough pilot testing of instruments and procedures helped us overcome barriers to conducting research in this vulnerable population. Keys to success included obtaining support from hospice medical directors, including hospice staff in study preparation, minimizing the burden on hospice staff, housing research staff in each participating hospice, using newsletters to enhance communication, developing and maintaining a detailed procedural manual, producing regular data quality reports, developing a secure site to facilitate coding videos for qualitative studies, and holding regular teleconferences with key staff. LIMITATIONS: Late enrollment of many patients in hospice left little to no time for their caregivers to take part in the intervention. Assisting caregivers of patients with very short life expectancy may require different methods.
CONCLUSIONS: The challenges of conducting randomized trials with hospice patients and caregivers can be addressed with appropriate study design, well-tested research methods, and proactive monitoring of any issues or problems.

Entities:  

Mesh:

Year:  2012        PMID: 23104974      PMCID: PMC3554844          DOI: 10.1177/1740774512461858

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  26 in total

1.  Conversion of the Caregiver Quality of Life Index to an interview instrument.

Authors:  K Courtney; G Demiris; D P Oliver; D Porock
Journal:  Eur J Cancer Care (Engl)       Date:  2005-12       Impact factor: 2.520

2.  Organizational structure, team process, and future directions of interprofessional health care teams.

Authors:  Kenneth D Cole; Martha S Waite; Linda O Nichols
Journal:  Gerontol Geriatr Educ       Date:  2003

3.  Palliative performance scale (PPS): a new tool.

Authors:  F Anderson; G M Downing; J Hill; L Casorso; N Lerch
Journal:  J Palliat Care       Date:  1996       Impact factor: 2.250

4.  Is the palliative performance scale a useful predictor of mortality in a heterogeneous hospice population?

Authors:  Joan Harrold; Elizabeth Rickerson; Janet T Carroll; Jennifer McGrath; Knashawn Morales; Jennifer Kapo; David Casarett
Journal:  J Palliat Med       Date:  2005-06       Impact factor: 2.947

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 6.  Designing research with hospice and palliative care populations.

Authors:  Ashley M Wohleber; Daniel S McKitrick; Shawn E Davis
Journal:  Am J Hosp Palliat Care       Date:  2011-11-21       Impact factor: 2.500

7.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

8.  Methodologic issues in collecting data from debilitated patients with cancer near the end of life.

Authors:  Susan C McMillan; Michael A Weitzner
Journal:  Oncol Nurs Forum       Date:  2003 Jan-Feb       Impact factor: 2.172

9.  Barriers to caregiver administration of pain medication in hospice care.

Authors:  Marijo Letizia; Steve Creech; Ellen Norton; Marie Shanahan; Lori Hedges
Journal:  J Pain Symptom Manage       Date:  2004-02       Impact factor: 3.612

10.  Communication patterns and technical quality of virtual visits in home care.

Authors:  George Demiris; Stuart Speedie; Stanley Finkelstein; Ilene Harris
Journal:  J Telemed Telecare       Date:  2003       Impact factor: 6.184

View more
  17 in total

1.  Using medical words with family caregivers.

Authors:  Elaine Wittenberg-Lyles; Joy Goldsmith; Debra Parker Oliver; George Demiris; Robin L Kruse; Stephanie Van Stee
Journal:  J Palliat Med       Date:  2013-08-12       Impact factor: 2.947

2.  Challenges in Implementing Hospice Clinical Trials: Preserving Scientific Integrity While Facing Change.

Authors:  Debra Parker Oliver; Karla T Washington; George Demiris; Patrick White
Journal:  J Pain Symptom Manage       Date:  2019-10-11       Impact factor: 3.612

Review 3.  Implementation science: implications for intervention research in hospice and palliative care.

Authors:  George Demiris; Debra Parker Oliver; Daniel Capurro; Elaine Wittenberg-Lyles
Journal:  Gerontologist       Date:  2013-04-04

4.  Exploring the collective hospice caregiving experience.

Authors:  Elaine Wittenberg-Lyles; Robin L Kruse; Debra Parker Oliver; George Demiris; Greg Petroski
Journal:  J Palliat Med       Date:  2013-12-18       Impact factor: 2.947

5.  The Social Convoy for Family Caregivers Over the Course of Hospice.

Authors:  David L Albright; Karla Washington; Debra Parker-Oliver; Alexandria Lewis; Robin L Kruse; George Demiris
Journal:  J Pain Symptom Manage       Date:  2015-11-03       Impact factor: 3.612

6.  Pain management and the African American hospice caregiver: a case report.

Authors:  Paula K Baldwin; Elaine Wittenberg-Lyles; Robin L Kruse; George Demiris; Debra Parker Oliver
Journal:  Am J Hosp Palliat Care       Date:  2012-12-10       Impact factor: 2.500

7.  A multimethod analysis of shared decision-making in hospice interdisciplinary team meetings including family caregivers.

Authors:  Karla T Washington; Debra Parker Oliver; L Ashley Gage; David L Albright; George Demiris
Journal:  Palliat Med       Date:  2015-08-17       Impact factor: 4.762

8.  Exploring oral literacy in communication with hospice caregivers.

Authors:  Elaine Wittenberg-Lyles; Joy Goldsmith; Debra Parker Oliver; George Demiris; Robin L Kruse; Stephanie Van Stee
Journal:  J Pain Symptom Manage       Date:  2013-03-21       Impact factor: 3.612

9.  Hospice Family Caregiver Involvement in Care Plan Meetings: A Mixed-Methods Randomized Controlled Trial.

Authors:  Debra Parker Oliver; George Demiris; Karla Washington; Robin L Kruse; Greg Petroski
Journal:  Am J Hosp Palliat Care       Date:  2016-07-27       Impact factor: 2.500

10.  Caregiver evaluation of the ACTIVE intervention: "it was like we were sitting at the table with everyone".

Authors:  Debra Parker Oliver; David L Albright; Robin L Kruse; Elaine Wittenberg-Lyles; Karla Washington; George Demiris
Journal:  Am J Hosp Palliat Care       Date:  2013-05-26       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.